CluePoints to Share Case Study on Technology ROI at The SCDM 2022 EMEA Leadership Forum & Conference
Decentralized clinical trials (DCTs) have become a buzzphrase in recent years, with commentators lining up to extol the benefits of this new way of working.…
Read More
Join us at DIA 2022 as we Demystify the De-risking of DCTs
The world of decentralized clinical trials (DCTs) and risk-based quality management is evolving rapidly – but CluePoints and our partners are here to help you…
Read More
10 Ways the Pandemic Changed CluePoints
Author: Patrick Hughes, Co-Founder & Chief Commercial Officer, CluePoints As CluePoints celebrates ten years as the leading provider of Risk-Based Study Execution (RBx) and Risk-Based…
Read More
10 Ways Mid-Sized BioPharma Has Applied a Pragmatic Approach to RBQM Implementation
Author: Dan Beaudry, Senior Vice President, Customer Success As the shift towards decentralized clinical trials accelerates, powered by the COVID-19 pandemic as well as the…
Read More
Does Central Monitoring Lead to Higher Quality? An Analysis of KRI Outcomes
Author: Sylviane de Viron, Manager, Data & Knowledge, CluePoints and William Steijn, Research Data Analyst, CluePoints Central Monitoring is a key component of Risk-Based Quality…
Read More
CluePoints Co-Founder and Chief Executive Officer to Speak at SCOPE Europe
Francois Torche, Co-Founder and Chief Executive Officer at CluePoints, will share insights into utilizing Risk-Based Quality Management (RBQM) to improve trial outcomes at this year’s…
Read More
FDA Places Quality Management at the Heart of Updated Inspection Guide
Author: Patrick Hughes, Co-Founder & Chief Commercial Officer, CluePoints It's official: Risk-Based Quality Management (RBQM) is essential for the smooth running of clinical trials. The…
Read More
CluePoints Wins Citeline Award for Excellence in Innovation in Response to COVID-19 – Clinical Trial Activities
Company wins prestigious accolade for contribution to Pfizer/BioNTech BNT162b2 COVID-19 vaccine development King of Prussia, PA – April 11, 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx)…
Read More
Events
Find out where we’re headed next.
Featured Whitepaper
ICH E6 (R2)
Summary
Paper
Created in conjunction with our peers at TUFTS Center for the Study of Drug Development, this paper provides insights on how companies are responding to ICH E6 (R2) and information on the key themes on adoption.
Featured Webinar
ICH E6 (R2)
Webinar
Series
This recorded webinar covers all of the frequently asked Questions about ICH E6 (R2), Risk-Based Study Execution (RBx) and what’s required from a people, process & technology standpoint.
We're Kind of a Big Deal.
3,400
Platform Users
700
Studies De-Risked
64,000
Issues Detected
